UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sex hormones, obesity and type 2 diabetes: is there a link?

Endocrine Connections, 2019-01, Vol.8 (1), p.R1-R9

2019

Volltextzugriff (PDF)

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

European journal of endocrinology, 2014-10, Vol.171 (4), p.P1-P29

2014

Volltextzugriff (PDF)

Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions

Frontiers in endocrinology (Lausanne), 2020-08, Vol.11, p.516

2020

Volltextzugriff (PDF)

An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence

Hormone research in paediatrics, 2017-01, Vol.88 (6), p.371-395

2017

Volltextzugriff (PDF)

Sindrome dell’ovaio policistico e infezione da COVID-19

L'Endocrinologo, 2022, Vol.23 (2), p.230-231

2022

Volltextzugriff (PDF)

Radioiodine whole body scan pitfalls in differentiated thyroid cancer

Endocrine, 2024-08, Vol.85 (2), p.493-508

2024

Volltextzugriff (PDF)

Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)—Women’s Endocrinology

Journal of endocrinological investigation, 2024-09, Vol.47 (9), p.2111-2141

2024

Volltextzugriff (PDF)

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk

Biomolecules (Basel, Switzerland), 2021-09, Vol.11 (9), p.1350

2021

Volltextzugriff (PDF)

Female infertility: which role for obesity?

International Journal of Obesity, 2019-04, Vol.9 (1), p.65-72

2019

Volltextzugriff (PDF)

Insulin-sensitizing agents in polycystic ovary syndrome

European journal of endocrinology, 2006-06, Vol.154 (6), p.763-775

2006

Volltextzugriff (PDF)

Maternal obesity: focus on offspring cardiometabolic outcomes

International Journal of Obesity, 2020-07, Vol.10 (1), p.27-34

2020

Volltextzugriff (PDF)

Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning

Experimental and Molecular Medicine, 2019, 51(0), , pp.1-17

2019

Volltextzugriff (PDF)

Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS

Journal of lipid research, 2012-03, Vol.53 (3), p.481-493

2012

Volltextzugriff (PDF)

Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism

Molecular metabolism (Germany), 2018-08, Vol.14, p.82-94

2018

Volltextzugriff (PDF)

Is it possible to achieve an acceptable disease control by dietary therapy alone in Berardinelli Seip type 1? Experience from a case report

Frontiers in endocrinology (Lausanne), 2023-06, Vol.14, p.1190363-1190363

2023

Volltextzugriff (PDF)

Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome

European journal of endocrinology, 2011-01, Vol.164 (1), p.53-60

2011

Volltextzugriff (PDF)

Le PCOS secondarie a endocrinopatie

L'Endocrinologo, 2021, Vol.22 (5), p.452-453

2021

Volltextzugriff (PDF)

European lipodystrophy registry: background and structure

Orphanet journal of rare diseases, 2020-01, Vol.15 (1), p.17-17, Article 17

2020

Volltextzugriff (PDF)

Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C

Frontiers in endocrinology (Lausanne), 2021-04, Vol.12, p.675096

2021

Volltextzugriff (PDF)

Efficacy of very low-calorie ketogenic diet with the Pronokal® method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial

Endocrine Connections, 2023-07, Vol.12 (7), p.1-13

2023

Volltextzugriff (PDF)

SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial

Trials, 2023-09, Vol.24 (1), p.589-589, Article 589

2023

Volltextzugriff (PDF)

Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome

Diagnostics (Basel), 2023-06, Vol.13 (12), p.2067

2023

Volltextzugriff (PDF)

A combination of polymorphisms in HSD11B1 associates with in vivo 11β-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome

European journal of endocrinology, 2011-08, Vol.165 (2), p.283-292

2011

Volltextzugriff (PDF)

Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women

Molecular metabolism (Germany), 2017-05, Vol.6 (5), p.406-415

2017

Volltextzugriff (PDF)

Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction

Cells (Basel, Switzerland), 2023-11, Vol.12 (22), p.2586

2023

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(155)
Buchkapitel
(11)
Bücher
(2)
Berichte
(1)

Sprache

Englisch
(159)
Italienisch
(10)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(96)
Science & Technology
(96)
Humans
(76)
Endocrinology & Metabolism
(65)
Female
(64)
Adult
(43)
Obesity
(33)
Biological And Medical Sciences
(29)
Polycystic Ovary Syndrome
(28)
Endocrinology
(27)
Medical Sciences
(26)
Insulin Resistance
(24)
Metabolic Diseases
(22)
Adolescent
(21)
Male
(21)
Middle Aged
(21)
Medicine
(18)
Polycystic Ovary Syndrome - Complications
(18)
Androgens
(17)
Internal Medicine
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sex hormones, obesity and type 2 diabetes: is there a link?

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions

An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence

Sindrome dell’ovaio policistico e infezione da COVID-19

Radioiodine whole body scan pitfalls in differentiated thyroid cancer

Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)—Women’s Endocrinology

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk

Female infertility: which role for obesity?

Insulin-sensitizing agents in polycystic ovary syndrome

Maternal obesity: focus on offspring cardiometabolic outcomes

Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning

Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS

Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism

Is it possible to achieve an acceptable disease control by dietary therapy alone in Berardinelli Seip type 1? Experience from a case report

Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome

Le PCOS secondarie a endocrinopatie

European lipodystrophy registry: background and structure

Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C

Efficacy of very low-calorie ketogenic diet with the Pronokal® method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial

Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome

A combination of polymorphisms in HSD11B1 associates with in vivo 11β-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome

Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women

Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction

Aktive Filter

Suchergebnisse filtern